Fig. 8
From: Empagliflozin protects the heart against ischemia/reperfusion-induced sudden cardiac death
The influence of U0126 on ventricular ERK1/2 phosphorylation. Western blots (A) and band densities (B) of ventricular phosphorylated ERK1/2 and total ERK1/2 in control and empagliflozin groups in the presence or absence of pharmacological inhibitor after 20 min of reperfusion (n = 5 per group). **P < 0.01 vs. sham, ##P < 0.01 vs. CON. Sham, sham-operated group; CON, control; Em, empagliflozin